Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by SIGURDSSON, E.
Right arrow Articles by THORGEIRSSON, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SIGURDSSON, E.
Right arrow Articles by THORGEIRSSON, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

research-article

Long-Term Prognosis of Different Forms of Coronary Heart Disease: The Reykjavik Study

EMIL SIGURDSSON*,**,{dagger}, NIKULAS SIGFUSSON*, UGGI AGNARSSON*, HELGI SIGVALDASON* and GUDMUNDUR THORGEIRSSON*,{ddagger}

* Heart Preventive Clinic Reykjavik, Iceland
** Department of Primary Health Care, University of Göteborg Gothenburg, Sweden.
{dagger} Health Centre of Mariestad Sweden
{ddagger} Department of Medicine, Landspitalinn, National University Hospital Reykjavik, Iceland

Reprint requests to: Dr Gudmundur Thorgeirsson, Department of Medicine, Landspitalinn, National University Hospital, Reykjavik, Iceland

Background. While coronary heart disease (CHD) is a serious and often fatal disease the prognosis is variable and major effort has been invested in risk stratification. The purpose of this study was to examine the relation between long-term prognosis and risk factors in different clinical categories of CHD.

Methods. A general population sample of 9141 men, aged 34–79 at entry into the study was divided into six groups with respect to manifestations of CHD at entry: I Symptomatic infarction II. Silent or unrecognized infarction III Angina pectons with ischaemic changes on ECG. IV. Angina without ischaemic changes V. Angina by Rose questionnaire but not confirmed by a physician. VI No manifestations of CHD.

Results. The risk factor profile varied considerably between the different categories and by life-table analysis marked differences in survival were demonstrated between the groups The risk factors maintained their detrimental effects on prognosis in the presence of CHD. Thus, age, serum total cholesterol, impaired glucose tolerance and smoking were found by Cox's regression to be statistically significant independent risk factors of CHD mortality among men having manifestations of CHD (groups I-V). Furthermore, the composite risk score, a measure of the overall risk factor exposures had marked effect on the prognosis of the various CHD groups. When the comprehensive risk factor score for both CHD mortality and all-cause mortality was accounted for marked differences persisted in the long-term prognosis. Compared to those without CHD the infarct groups had about a 7.6- and 3.7-fold risk of dying from CHD and all causes respectively. Those with angina had from 2.5- to 3.2-fold risk of CHD mortality and 1.7- to 2.2-fold risk of all-cause mortality depending on the subgroup of angina, again compared to those without manifestations of CHD.

Conclusion. Different categones of CHD had different risk factor profiles and the long-term prognosis resulted from a complex interplay between those factors and the diagnostic category of CHD. The risk factors maintained their detrimental effects on prognosis in the presence of CHD and after accounting for the comprehensive risk factor score marked differences persisted in the long-term prognosis, being worst for those having suffered a myocardial infarction, either symptomatic or silent.

Received 1 June 1994


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HeartHome page
N F Murphy, S Stewart, C L Hart, K MacIntyre, D Hole, and J J V McMurray
A population study of the long-term consequences of Rose angina: 20-year follow-up of the Renfrew-Paisley study
Heart, December 1, 2006; 92(12): 1739 - 1746.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Capewell, N F Murphy, K MacIntyre, S Frame, S Stewart, J W T Chalmers, J Boyd, A Finlayson, A Redpath, and J J V McMurray
Short-term and long-term outcomes in 133 429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study
Heart, November 1, 2006; 92(11): 1563 - 1570.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. de Torbal, E. Boersma, J. A. Kors, G. van Herpen, J. W. Deckers, D. A.M. van der Kuip, B. H. Stricker, A. Hofman, and J. C.M. Witteman
Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study
Eur. Heart J., March 2, 2006; 27(6): 729 - 736.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J Bodegard, G Erikssen, J V Bjornholt, D Thelle, and J Erikssen
Possible angina detected by the WHO angina questionnaire in apparently healthy men with a normal exercise ECG: coronary heart disease or not? A 26 year follow up study
Heart, June 1, 2004; 90(6): 627 - 632.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Thorsson, G. Sigurdsson, and V. Gudnason
Systematic Family Screening for Familial Hypercholesterolemia in Iceland
Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 335 - 338.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F.C Lampe, P.H Whincup, S.G Wannamethee, A.G Shaper, M Walker, and S Ebrahim
The natural history of prevalent ischaemic heart disease in middle-aged men
Eur. Heart J., July 1, 2000; 21(13): 1052 - 1062.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
U. Agnarsson, G. Thorgeirsson, H. Sigvaldason, and N. Sigfusson
Effects of Leisure-Time Physical Activity and Ventilatory Function on Risk for Stroke in Men: The Reykjavik Study
Ann Intern Med, June 15, 1999; 130(12): 987 - 990.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. S. Forrester and P. K. Shah
Lipid Lowering Versus Revascularization : An Idea Whose Time (For Testing) Has Come*
Circulation, August 19, 1997; 96(4): 1360 - 1362.
[Abstract] [Full Text]


Home page
BMJHome page
J Shepherd
Cost effectiveness of lowering cholesterol
BMJ, November 2, 1996; 313(7065): 1142 - 1142.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.